Bioneutra Global Stock Performance
| BGACF Stock | USD 0.07 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioNeutra Global are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BioNeutra Global has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, BioNeutra Global is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 933.8 K | |
| Total Cashflows From Investing Activities | -276.8 K |
BioNeutra |
BioNeutra Global Relative Risk vs. Return Landscape
If you would invest 6.70 in BioNeutra Global on August 26, 2024 and sell it today you would earn a total of 0.00 from holding BioNeutra Global or generate 0.0% return on investment over 90 days. BioNeutra Global is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than BioNeutra, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioNeutra Global Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNeutra Global's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as BioNeutra Global, and traders can use it to determine the average amount a BioNeutra Global's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BGACF |
Based on monthly moving average BioNeutra Global is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioNeutra Global by adding BioNeutra Global to a well-diversified portfolio.
BioNeutra Global Fundamentals Growth
BioNeutra Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioNeutra Global, and BioNeutra Global fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioNeutra Pink Sheet performance.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.0573 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 5 M | |||
| Shares Outstanding | 46.45 M | |||
| Price To Sales | 0.25 X | |||
| Revenue | 15.4 M | |||
| EBITDA | (1.12 M) | |||
| Cash And Equivalents | 1.93 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 6.34 M | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | 271.05 K | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 21.08 M | |||
About BioNeutra Global Performance
By analyzing BioNeutra Global's fundamental ratios, stakeholders can gain valuable insights into BioNeutra Global's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioNeutra Global has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioNeutra Global has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. Bioneutra Global is traded on OTC Exchange in the United States.Things to note about BioNeutra Global performance evaluation
Checking the ongoing alerts about BioNeutra Global for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioNeutra Global help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioNeutra Global generated a negative expected return over the last 90 days | |
| BioNeutra Global has some characteristics of a very speculative penny stock | |
| BioNeutra Global has high likelihood to experience some financial distress in the next 2 years | |
| BioNeutra Global has accumulated 6.34 M in total debt. BioNeutra Global has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BioNeutra Global until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutra Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutra Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutra to invest in growth at high rates of return. When we think about BioNeutra Global's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 15.4 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| About 37.0% of the company shares are held by company insiders |
- Analyzing BioNeutra Global's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioNeutra Global's stock is overvalued or undervalued compared to its peers.
- Examining BioNeutra Global's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioNeutra Global's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioNeutra Global's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioNeutra Global's pink sheet. These opinions can provide insight into BioNeutra Global's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioNeutra Pink Sheet analysis
When running BioNeutra Global's price analysis, check to measure BioNeutra Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNeutra Global is operating at the current time. Most of BioNeutra Global's value examination focuses on studying past and present price action to predict the probability of BioNeutra Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNeutra Global's price. Additionally, you may evaluate how the addition of BioNeutra Global to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance |